なぜ 臨床試験で 身体検査をするのか? 2型糖尿病における薬物介入試験の用例
Julia Kopanz1, Amy Rogers2, Lina Pérez-Breva3
1Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.
British journal of clinical pharmacology
|September 2, 2025
まとめ
2型糖尿病の臨床試験における身体検査 (PE) はよく定義されていない. 多くのプロトコルには,PEの目的と実施に関する詳細が欠けていて,試験の一貫性に影響を与え,その必要性や革新的な応用に関するさらなる研究が必要である.
科学分野:
- 臨床試験の方法論
- 薬理学研究
- 糖尿病の管理
背景:
- 身体検査 (PE) は臨床評価の構成要素です.
- 特に2型糖尿病 (T2DM) に関する介入薬試験におけるその特定の役割は明確化する必要があります.
研究 の 目的:
- 2型糖尿病に対する薬物介入臨床試験の第3段階および第4段階における身体検査 (PE) の目的と利用を決定する.
- 試験プロトコル内の PE 特性に関する文書の評価
主な方法:
- ClinicalTrials.govから 226件の臨床試験プロトコルの 体系的なレビュー
- 5人の研究者による PEの頻度,タイミング,目的,要素,行動に関するデータの抽出
主要な成果:
- 審査された211件のプロトコルのうち190件 (89%) で PEが言及され,241件の別々のPEが評価されました.
- 副作用の特定 (40%) とエンドポイントの評価 (33%) のために,PEの目的が明示的に記載されているのは,プロトコルの65%にすぎません.
- PEsの60%は試験の要素を記述したが,行動手順を指定したのはわずか8%であった.
結論:
- 臨床試験のプロトコルには,身体検査の目的,要素,実施に関する適切な情報がしばしば欠けています.
- この欠陥は臨床試験データの一貫性と信頼性を損なう可能性があります.
- すべての試験における PE の必要性を確認し,分散化などの革新的な試験設計に PE の統合を検討するために,さらなる調査が必要である.
さらに関連する動画
関連する概念動画
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Clinical Trials
7.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
7.8K
Diabetes: Management and Pharmacotherapy
354
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
354
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications
685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685


